Platelet rich plasma injection grafts for musculoskeletal injuries: a review

Steven Sampson, Michael Gerhardt, Bert Mandelbaum, Steven Sampson, Michael Gerhardt, Bert Mandelbaum

Abstract

In Europe and the United States, there is an increasing prevalence of the use of autologous blood products to facilitate healing in a variety of applications. Recently, we have learned more about specific growth factors, which play a crucial role in the healing process. With that knowledge there is abundant enthusiasm in the application of concentrated platelets, which release a supra-maximal quantity of these growth factors to stimulate recovery in non-healing injuries. For 20 years, the application of autologous PRP has been safely used and documented in many fields including; orthopedics, sports medicine, dentistry, ENT, neurosurgery, ophthalmology, urology, wound healing, cosmetic, cardiothoracic, and maxillofacial surgery. This article introduces the reader to PRP therapy and reviews the current literature on this emerging treatment modality. In summary, PRP provides a promising alternative to surgery by promoting safe and natural healing. However, there are few controlled trials, and mostly anecdotal or case reports. Additionally the sample sizes are frequently small, limiting the generalization of the findings. Recently, there is emerging literature on the beneficial effects of PRP for chronic non-healing tendon injuries including lateral epicondylitis and plantar fasciitis and cartilage degeneration (Mishra and Pavelko, The American Journal of Sports Medicine 10(10):1-5, 2006; Barrett and Erredge, Podiatry Today 17:37-42, 2004). However, as clinical use increases, more controlled studies are needed to further understand this treatment.

Figures

Fig. 1
Fig. 1
Inactive platelets
Fig. 2
Fig. 2
Active platelets
Fig. 3
Fig. 3
GPS III system and centrifuge
Fig. 4
Fig. 4
GPS III system, withdrawing of platelet poor plasma to be discarded
Fig. 5
Fig. 5
GPS III withdrawing of platelet rich plasma for injection/graft
Fig. 6
Fig. 6
Musculoskeletal ultrasound, common extensor tendinosis
Fig. 7
Fig. 7
Ultrasound guided suprapatella bursa injection/graft
Fig. 8
Fig. 8
Ultrasound guided knee MCL injection/graft

References

    1. Mishra A, Pavelko T. Treatment of chronic elbow tendinosis with buffered platelet-rich plasma. Am J Sports Med. 2006;10(10):1–5.
    1. Barrett S, Erredge S. Growth factors for chronic plantar fascitis. Podiatry Today. 2004;17:37–42.
    1. Woolf AD, Pfleyer B. Burdon of major musculoskeletal conditions. Bull World Health Organ. 2003;81:646–56.
    1. Anitua M, Sánchez E, Nurden A, Nurden P, Orive G, Andía I. New insights into and novel applications for platelet-rich fibrin therapies. Trends Biotechnol. 2006;24(5):227–34. doi: 10.1016/j.tibtech.2006.02.010.
    1. Praemer AF. Musculoskeletal conditions in the United States. 2. Rosemont: American Academy of Orthopaedic Surgeons; 1999.
    1. Marx R, Garg A. Dental and craniofacial applications of platelet-rich plasma. Carol Stream: Quintessence Publishing Co, Inc.; 2005.
    1. Everts P, Knape J, Weirich G, Schonberger J, Hoffman J, Overdevest E, et al. Platelet-rich plasma and platelet gel: a review. JECT. 2006;38:174–87.
    1. Pietrzak W, Eppley B. Scientific foundations platelet rich plasma: biology and new technology. J Craniofac Surg. 2005;16(6):1043–54. doi: 10.1097/.
    1. Marx RE. Platelet-rich plasma (PRP): what is PRP and what is not PRP? Implant Dent. 2001;10:225–8.
    1. Ferrari M, Zia S, Valbonesi M. A new technique for hemodilution, preparation of autologous platelet-rich plasma and intraoperative blood salvage in cardiac surgery. Int J Artif Organs. 1987;10:47–50.
    1. Antitua E, Andia I, Sanchez M, Azofra J, Del Mar Zalduendo M, Fuente M, et al. Autologous preparations rich in growth factors promote proliferation and induce VEGF and HGF productions by human tendon cells in culture. J Orthop Res. 2005;23:281–6. doi: 10.1016/j.orthres.2004.08.015.
    1. Fenwick SA, Hazlelman BL, Riley GP. The vasulature and its role in the damaged and healing tendon. Arthritis Res. 2002;4:252–60. doi: 10.1186/ar416.
    1. Hayem G. Tenology: a new frontier. Joint, Bone, Spine. Rev Rhum. 2001;68:19–25.
    1. Jobe F, Ciccotti M. Lateral and medial epicondylitis of the elbow. J Am Acad Orthop Surg. 1994;2:1–8.
    1. Edwards SG, Calandruccio JH. Autologous blood injections for refractory lateral epicondylitis. Am J Hand Surg. 2003;28(2):272–8. doi: 10.1053/jhsu.2003.50041.
    1. Antiua E, Sanchez M, Nurden A, Zalduendo M, Fuente M, Prive G, et al. Autologous fibrin matrices: a potential source of biological mediators that modulate tendon cell activities. J Biomed Mater Res Pt A. 2006;77(2):285–93. doi: 10.1002/jbm.a.30585.
    1. Kader D, Sakena A, Movin T, Magulli N. Achilles tendinopathy: some aspects of basic science and clinical management. Br J Sports Med. 2002;36:239–49. doi: 10.1136/bjsm.36.4.239.
    1. Smidt N, Assendelft W, Arola H, et al. Effectiveness of physiotherapy for lateral epicondylitis: a systemic review. Ann Med. 2003;35:51–62. doi: 10.1080/07853890310004138.
    1. Werner S, Grose R. Regulation of wound healing by growth factors and cytokines. Physiol Rev. 2003;83:835–70.
    1. Kirker-Head CA. Potential applications and delivery strategies for bone morphogenetic proteins. Adv Drug Deliv Rev. 2000;43:65–92. doi: 10.1016/S0169-409X(00)00078-8.
    1. Froum SJ, Wallace S, Tarnow DP, Cho SC. Effect of platelet-rich plasma on bone growth and osseointegration in human maxillary sinus grafts: three bilateral case reports. Int J Periodontics Restorative Dent. 2002;22:45–53.
    1. Raghoebar GM, Schortinghuis J, Liem R, Ruben J, Wal J, Vissink A. Does platelet-rich plasma promote remodeling of autologous bone grafts used for the augmentation of the maxillary sinus floor? Clin Oral Implants Res. 2005;16:349–56. doi: 10.1111/j.1600-0501.2005.01115.x.
    1. Molloy T, Wang Y, Murrell G. The roles of growth factors in tendon and ligament healing. Sports Med. 2003;33(5):381–94. doi: 10.2165/00007256-200333050-00004.
    1. Ranly D, Lohmann C, Andreacchio D, Boyan B, Schwartz Z. Platelet-rich plasma inhibits demineralized bone matrix-induced bone formation in nude mice. J Bone Joint Surg. 2007;89:139–46. doi: 10.2106/JBJS.F.00388.
    1. Eppley B, Woodell J, Higgins J. Platelet Quantification and growth factor analysis from platelet-rich plasma: Implications for wound healing. Plast Reconstr Surg. 2004;114(6):1502–7. doi: 10.1097/01.PRS.0000138251.07040.51.
    1. Zehnder JL, Leung LLK. Development of antibodies to thrombin and factor V with recurrent bleeding in a patient exposed to topical bovine thrombim. Blood. 1990;76:2011–6.
    1. Kajikawa Y, Morihara T, Sakamoto H, Matsuda K, Oshima Y, Yoshida A, et al. Platelet-rich plasma enhances the initial mobilization of circulation-derived cells for tendon healing. J Cell Physiol. 2008;215(3):837–45.
    1. Taylor M, Norman T, Clovis N, Blaha D. The response of rabbit patellar tendons after autologous blood injection. Med Sci Sports Exerc. 2002;34(1):70–3. doi: 10.1097/00005768-200201000-00012.
    1. Berghoff W, Pietrzak W, Rhodes R. Platelet-rich plasma application during closure following total knee arthroplasty. Orthopedics. 2006;29(7):590–8.
    1. Gardner MJ, Demetrakopoulos D, Klepchick P, Mooar P. The efficacy of autologous platelet gel in pain control and blood loss in total knee arthroplasty: an analysis of the haemoglobin, narcotic requirement and range of motion. Int Orthop. 2006;31:309–13. doi: 10.1007/s00264-006-0174-z.
    1. Everts P, Devilee R, Mahoney C, Eeftinck-Schattenenkerk M, Knape J, Zundert A. Platelet gel and fibrin sealant reduce allogeneic blood transfusions in total knee arthroplasty. Acta Anaesthesiol Scand. 2006;50:593–9. doi: 10.1111/j.1399-6576.2006.001005.x.
    1. Crovetti G, Martinelli G, Issi M, Barone M, Guizzardi M, Campanati B, et al. Platelet gel for healing cutaneous chronic wounds. Transfus Apher Sci. 2004;30:145–51. doi: 10.1016/j.transci.2004.01.004.
    1. McAleer JP, Kaplan E, Persich G. Efficacy of concentrated autologous platelet-derived growth factors in chronic lower-extremity wounds. J Am Podiatr Med Assoc. 2006;96(6):482–8.
    1. Ghandi A, Dumas C, O’Connor J, Parsons J, Lin S. The effects of local platelet rich plasma delivery on diabetic bone fracture healing. Bone. 2006;38:540–6. doi: 10.1016/j.bone.2005.10.019.
    1. Beam HA, Parsons JR, Lin SS. The effects of blood glucose control upon fracture healing in the BB Wistar rat with diabetes mellitus. J Orthop Res. 2002;20:1210–6. doi: 10.1016/S0736-0266(02)00066-9.
    1. Hee HT, Majd ME, Holt RT, Myers L. Do autologous growth factors enhance transforaminal lumbar interbody fusion? Eur Spine J. 2003;12(12):400–7. doi: 10.1007/s00586-003-0548-5.
    1. Carreon LY, Glassman SD, Anekstein Y, Puno RM. Platelet gel (AGF) fails to increase fusion rates in instrumented posterolateral fusions. Spine. 2005;30(9):E243–6. doi: 10.1097/01.brs.0000160846.85397.44.
    1. Jenis LG, Banco RJ, Kwon B. A prospective study of Autologous Growth Factors (AGF) in lumbar interbody fusion. Spine J. 2006;6(1):14–20. doi: 10.1016/j.spinee.2005.08.014.
    1. Castro FP., Jr Role of activated growth factors in lumbar spinal fusions. J Spinal Disord Tech. 2004;17(5):380–4. doi: 10.1097/01.bsd.0000110342.54707.19.
    1. Weiner BK, Walker M. Efficacy of autologous growth factors in autologous intertransverse fusions. Spine. 2003;28:1968–70. doi: 10.1097/01.BRS.0000083141.02027.48.
    1. Lowery GL, Kulkarni S, Pennisi AE. Use of autologous growth factors in lumbar spine fusion. Bone. 1999;25:47S–50S. doi: 10.1016/S8756-3282(99)00132-5.
    1. Chen W, Lo WC, Lee JJ, Su CH, Lin CT, Liu HY, et al. Tissue-engineered intervertebral disc and chondrogenesis using human nucleus pulposus regulated through TGF-beta1 in platelet-rich plasma. J Cell Physiol. 2006;209(3):744–54. doi: 10.1002/jcp.20765.
    1. Hunziker EB, Driesang IM, Morris EA. Clinical orthopaedics and related research. Chondrogenesis in cartilage repair is induced by members of the transforming growth factor-beta superfamily. Clin Orthop Relat Res. 2001;391(Suppl):S171–81. doi: 10.1097/00003086-200110001-00017.
    1. Nakagawa K, Sasho T, Arai M, Kitahara S, Ogino S, Wada Y, et al. Effects of autologous platelet-rich plasma on the metabolism of human articular chondrocytes. Chiba and Ichihara, Japan. Electronic poster presentation P181. International Cartilage Repair Society Meeting, Warsaw Poland, October 2007.
    1. Kon E, Filardo G, Presti ML, Delcogliano M, Iacono F, Montaperto C, et al. Utilization of platelet-derived growth factors for the treatment of cartilage degenerative pathology. Bologna, Italy. Electronic poster presentation 29.3. International Cartilage Repair Society Meeting, Warsaw Poland, October 2007.
    1. Anitua E, Sánchez M, Nurden AT, Zalduendo MM, Fuente M, Azofra J, et al. Platelet-released growth factors enhance the secretion of hyaluronic acid and induce hepatocyte growth factor production by synovial fibroblasts from arthritic patients. Rheumatology. 2007;46(12):1769–72. doi: 10.1093/rheumatology/kem234.
    1. Wu W, Chen F, Liu Y, Ma Q, Mao T. Autologous injectable tissue-engineered cartilage by using platelet-rich plasma: experimental study in a rabbit model. J Oral Maxillofac Surg. 2007;65(10):1951–7. doi: 10.1016/j.joms.2006.11.044.

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅